Trial intelligence / Profile preview

Comparison of three techniques in the management of postoperative acute pain after general anesthesia based on nociception control

2016-002824-98Phase 4Terminated

Sponsor
Vall d'Hebron Research Institute
Start
Aug 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remifentanil in acute postoperative pain (3 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Pupillary diameter (RDP). Started Aug 2016; status: terminated.

02

Drugs

remifentanil
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on 2016-002824-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002824-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call